---
title: "CARE Ratings Ltd (CARERATING) — Share Price, Financials & Analysis"
symbol: "CARERATING"
company: "CARE Ratings Ltd"
canonical: "https://tapetide.com/stocks/CARERATING"
isin: "INE752H01013"
nse_symbol: "CARERATING"
bse_code: "534804"
sector: "Financial Services"
industry: "Rating Services"
market_cap_cr: 4981.55
generated_at: "2026-09-13T18:59:04.157Z"
---

# CARE Ratings Ltd (CARERATING)

Canonical page: https://tapetide.com/stocks/CARERATING

## Company

- **NSE Symbol:** CARERATING
- **BSE Code:** 534804
- **ISIN:** INE752H01013
- **Sector:** Financial Services
- **Industry:** Rating Services
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2012-12-26
- **CEO:** Mr. Mehul Harshadray Pandya
- **Employees:** 598
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** careratings.com

## About

CARE Ratings is a leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own riskreturn expectations.(Source : 202003-01 Annual Report Page No:134)

## Latest Price

- **Price:** ₹1650.5
- **Change:** -42.5 (-2.51%)
- **Open:** ₹1680
- **Day High:** ₹1680.2
- **Day Low:** ₹1645.3
- **Previous Close:** ₹1693
- **Volume:** 49841
- **As Of:** 2026-09-11T10:26:22+00:00

## Key Fundamentals

Observed at 2026-09-11T04:36:37.868572Z.

- **Market Cap:** ₹4981.55 Cr
- **Classification:** Microcap
- **P/E (reported):** 28.3
- **P/E (TTM):** 27.9
- **EPS (TTM):** ₹59.16
- **EPS (reported):** ₹34.6
- **Book Value:** ₹309.57
- **Price to Book:** 5.48
- **Dividend Yield:** 1.3%
- **ROE:** 18.42%
- **ROCE:** 24.1%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹527.9 Cr
- **Net Income:** ₹173.7 Cr
- **EBITDA:** ₹252.2 Cr
- **52-Week High:** ₹1838
- **52-Week Low:** ₹1392.7
- **RSI (14):** 49.04

## Tapetide Score

- **Score:** 64 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 95.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 76.25 | 9% |
| growth | 61.06 | 9% |
| momentum | 79.45 | 12% |
| ownership | 60.66 | 24% |
| quality | 77.96 | 22% |
| valuation | 43.13 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 43.8%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 20.02% | 62.38% | 117.01% |
| ebitda margin growth | -35.42% | 5.03% | 13.82% | 22.95% |
| net income growth | -38.32% | 24.07% | 27% | 14% |
| revenue growth | -13.59% | 16.51% | 19% | 14% |
| roce | -37.27% | 6.64% | 23.97% | 19.72% |
| roe | -38.28% | 7.28% | 16.58% | 56.5% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 |
| Expenses | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 |
| Operating Profit | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 |
| OPM % | 43 | 30 | 32 | 28 | 47 | 32 | 43 | 30 | 50 | 36 | 46 | 31 |
| Other Income | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 |
| Tax % | 29 | 30 | 32 | 30 | 27 | 27 | 26 | 29 | 26 | 25 | 26 | 27 |
| Net Profit | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 |
| EPS in Rs | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 | 11.96 | 17.58 | 10.73 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 473 | 491 |
| Expenses | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 276 | 287 |
| Operating Profit | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 197 | 204 |
| OPM % | 63 | 55 | 33 | 39 | 32 | 36 | 34 | 39 | 42 | 42 |
| Other Income | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 55 | 56 |
| Interest | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 14 | 15 |
| Profit before tax | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 235 | 243 |
| Tax % | 30 | 32 | 20 | 23 | 22 | 32 | 30 | 27 | 26 | — |
| Net Profit | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 174 | 180 |
| EPS in Rs | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 56.97 | 59.16 |
| Dividend Payout % | 100 | 64 | 70 | 56 | 67 | 89 | 53 | 39 | 39 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 |
| Reserves | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 | 902 |
| Borrowings | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 | 26 |
| Other Liabilities | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 | 146 |
| Total Liabilities | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1105 |
| Fixed Assets | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 | 122 |
| CWIP | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 | 5 |
| Investments | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 | 87 |
| Other Assets | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 | 890 |
| Total Assets | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1105 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 119 | 134 | 109 | 67 | 86 | 68 | 82 | 91 | 123 | 148 |
| Cash from Investing Activity | -22 | -25 | 83 | 27 | -38 | -27 | 13 | -39 | -58 | -94 |
| Cash from Financing Activity | -96 | -99 | -195 | -107 | -43 | -35 | -63 | -63 | -54 | -59 |
| Net Cash Flow | 1 | 11 | -4 | -13 | 5 | 6 | 32 | -11 | 11 | -6 |
| Free Cash Flow | 118 | 131 | 82 | 63 | 82 | 49 | 71 | 82 | 108 | 140 |
| CFO/OP | 101 | 95 | 98 | 125 | 114 | 122 | 115 | 119 | 112 | 107 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Cash Conversion Cycle | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Working Capital Days | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 | 316 |
| ROCE % | 44 | 41 | 35 | 19 | 21 | 16 | 19 | 21 | 25 | 26 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 20.9% | 21.67% | 22.91% | 23.37% | 24.8% | 24.75% | 23.74% | 24.62% | 23.61% | 23% | 23.25% | 23.41% |
| DIIs | 23.73% | 21.65% | 26.89% | 26.15% | 25.28% | 27.51% | 29.38% | 29.76% | 31.6% | 31.3% | 31.39% | 31.58% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 32.95% | 29.86% | 27.95% | 28% | 27.64% | 26.16% | 25.48% | 25.04% | 24.78% | 25.33% | 24.94% | 24.75% |
| Others | 22.43% | 26.81% | 22.26% | 22.48% | 22.28% | 21.58% | 21.39% | 20.59% | 20.01% | 20.36% | 20.43% | 20.26% |
| No. of Shareholders | 55721 | 54539 | 52468 | 53140 | 53602 | 52007 | 51395 | 61111 | 56931 | 59139 | 58978 | 58466 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 7 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1708.21 | Sell |
| EMA (10) | 1696.66 | Sell |
| SMA (20) | 1690.78 | Sell |
| EMA (20) | 1696.29 | Sell |
| SMA (50) | 1690.32 | Sell |
| EMA (50) | 1688.17 | Sell |
| SMA (100) | 1672.98 | Sell |
| EMA (100) | 1668.83 | Sell |
| SMA (200) | 1627.18 | Buy |
| EMA (200) | 1631.96 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.79 | Neutral |
| MACD (12,26,9) | 1.47 | Sell |
| Stochastic (14,3,3) | 45.32 | Neutral |
| ADX (14) | 21.77 | Neutral |
| Williams %R (14) | -72.44 | Neutral |
| ATR (14) | 54.09 | High Volatility |
| ROC (12) | -0.63 | Sell |
| Stoch RSI (14) | 31.69 | Neutral |
| UO (7,14,28) | 37.23 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8h - Corrects earlier disclosure: FIR number is 322 of 2025 (previously misstated as 544/2024). | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 8h - Corrects earlier disclosure: FIR number is 322 of 2025 (previously misstated as 544/2024).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc5232ea-a61f-41fe-bd2a-c3a774e43091.pdf) |
| 8 Apr - CARE Ratings says it is not a Large Corporate; FY26-27 initial disclosure and FY25-26 annual disclosure not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 8 Apr - CARE Ratings says it is not a Large Corporate; FY26-27 initial disclosure and FY25-26 annual disclosure not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0ed3c6f-4a39-4f78-b8eb-eb2c7fd064cf.pdf) |
| 8 Apr - CARE Ratings confirms it is not a Large Corporate for FY2025-26 and FY2026-27 disclosures are not applicable. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 8 Apr - CARE Ratings confirms it is not a Large Corporate for FY2025-26 and FY2026-27 disclosures are not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc9d6d42-f1fb-4cb8-bf8b-300539f2477b.pdf) |
| 7h - Board meets May 13, 2026 to approve FY26 audited results and consider final dividend. | [Board Meeting Intimation for To Consider And Approve The Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Financial Year Ended On March 31, 2026 And To Recommend Final Dividend, If Any, For The Financial Year 2025-26 7h - Board meets May 13, 2026 to approve FY26 audited results and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9c257809-cd1b-48f5-816e-fc833c99c992.pdf) |
| 7 Feb - Board meeting Feb 14, 2026 to approve unaudited Q3 & 9M FY2026 results; trading window closed. | [Board Meeting Intimation for Consideration & Approval Of Quarterly Financial Results 7 Feb - Board meeting Feb 14, 2026 to approve unaudited Q3 & 9M FY2026 results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc7b4733-43f2-4859-906f-1f301a76c159.pdf) |
| 6 Mar - Allotment of 1,650 Equity shares pursuant to exercise of ESOP | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 6 Mar - Allotment of 1,650 Equity shares pursuant to exercise of ESOP](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b069bbb-78a0-490f-a013-621e814ee34f.pdf) |
| 6 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bb8732a-c25b-4b70-ab20-2dc883d2becc.pdf) |
| 6 Apr - Allotment of 1,850 Equity shares pursuant to exercise of ESOP | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 6 Apr - Allotment of 1,850 Equity shares pursuant to exercise of ESOP](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38b185eb-28ae-491e-b456-e41b7103bf52.pdf) |
| 5 May - CARE Ratings schedules Q4 and FY2026 earnings call on May 14, 2026 at 1:30 PM IST. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 5 May - CARE Ratings schedules Q4 and FY2026 earnings call on May 14, 2026 at 1:30 PM IST.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2aaae87f-0283-4fef-911e-da2173936ca8.pdf) |
| 4 May - CARE Ratings and NSE commercially launched PaRRVA, a standardized investment performance verification platform, on May 4, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 4 May - CARE Ratings and NSE commercially launched PaRRVA, a standardized investment performance verification platform, on May 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1daa239-e68a-4c4a-8b88-b432d62c223c.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42dc9be0-bd78-40f8-a0d5-3fac9d68fbd0.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=305eb80a-3d3d-41b7-a666-90818b9f65ea.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fee09d32-a913-4f51-b240-1acdf1497838.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6243d4c4-a08d-4c94-bec1-7086f3d32a24.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47149aeb-3910-41f4-9b33-ce1f4a039143.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b1b0ab6-68f6-4141-90d2-51631e40c3c2.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29d18d2c-d143-4c61-956f-e06c50299f91.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=294d5bb2-c339-45fa-aceb-a3abce17d9b9.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b7cebc3-dc13-4b23-bb70-14b7f4c52bf2.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7dee57e-5a1d-4780-bde6-7235f480b3a2.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Outcome Of The Meeting Of The Board Of Directors Of CARE Ratings Limited Held On August 7 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a6cb691-09f5-4b8f-a9bb-5123c4f9552c.pdf) |
| 2026-05-13 | [Financial Results For Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15b8bdf1-5521-4b36-b2a5-c6819114a462.pdf) |
| 2026-02-11 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aff53e07-91f3-4fd1-aa78-ade4a999f2b8.pdf) |
| 2025-11-12 | [Financial Results For Quarter And Half Year Ended On September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63586397-fd02-442b-a459-d1299ab310e7.pdf) |
| 2025-08-05 | [Outcome Of Board Meeting Dated 05-08-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3af8ad1d-911a-496f-89fa-8f42426c4d92.pdf) |
| 2025-05-12 | [Outcome Of Board Meeting Dated 12Th May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c50e4bc-ad0e-4ae8-bf80-9fbb9f9d3b41.pdf) |
| 2025-01-30 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d201bc-5be2-4d0f-a176-43edde0a41cf.pdf) |
| 2024-10-23 | [Outcome Of Board Meeting Dated 23-10-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c877fdd-eb4b-4f91-9fde-885daca65f49.pdf) |
| 2024-08-07 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb8855e0-1c10-4776-9338-18136f51275c.pdf) |
| 2024-08-07 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bfdd96b-acb9-455a-9a71-52c8e4267c24.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3061228e-bbb6-4082-8e03-329b1c304a03.pdf) |
| 2026-05-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08ab63b0-00e0-4e8b-ae74-81a79feef3aa.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d18c03e-42da-480d-8d26-c95605c2c394.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6542e649-a015-4041-957a-edeee0661fd8.pdf) |
| 2025-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd1745d5-bc98-4c85-8639-a2f859385e0d.pdf) |
| 2025-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b309152-f47f-47a6-975c-d1b0286368de.pdf) |
| 2025-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bd7032f-61dd-4198-accb-a8862d1a905e.pdf) |
| 2024-10-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2be2778f-b21c-45b1-9490-44e25075169c.pdf) |
| 2024-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c77b43d-ecb6-429c-906a-35fc2ce3aef9.pdf) |
| 2024-05-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75589ad5-38a1-46e7-ab49-44daf02fd19f.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6154481-389a-4598-a678-fae9af13aa2b.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e162a872-c59f-4963-ab61-7b84e228cf87.pdf) |
| 2024-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faed5da9-6c11-441e-af5d-8281ef064e9b.pdf) |
| 2024-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ffb23b1-d315-4cbb-922e-8d2f9dc176ad.pdf) |
| 2023-05-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bca467cb-8932-4d52-b4e4-36c3edeb2a91.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-05-14 | [Audio Recording Of Earnings Conference Call For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aef28d1-ce7f-42f2-b362-315587e53210.pdf) |
| 2025-05-14 | [CARE Ratings Limited - Earnings Call - Link Of Audio Recording](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c1eb1c-461b-41ea-bbe6-12add93c0f8f.pdf) |
| 2024-05-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e37cb2f4-4341-4470-9342-1ae23206d836.pdf) |
| 2023-05-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7266f49-1e6b-4120-97ca-6629a7ed8267.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2be2778f-b21c-45b1-9490-44e25075169c.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88950a9e-cbde-4f1e-bf46-903de05b8efd.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6542e649-a015-4041-957a-edeee0661fd8.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ec3a2f3-6107-4aa1-8453-3776a5d95786.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08ab63b0-00e0-4e8b-ae74-81a79feef3aa.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3ec3a2f3-6107-4aa1-8453-3776a5d95786.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/08ab63b0-00e0-4e8b-ae74-81a79feef3aa.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c6511c7-db19-4c24-ae13-12e71af1fef4.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c6511c7-db19-4c24-ae13-12e71af1fef4.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5bd7032f-61dd-4198-accb-a8862d1a905e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/39c32185-731c-46d1-8131-dcba8f85f371.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/323d2adc-b90b-4065-a009-bb18f0e8bac0.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/daab521c-f98f-4cdd-bcce-c723fa491fde.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d27c8990-03a2-4fb7-9913-1adf770db0f2.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d65d18a-44d7-48d2-8ca3-2e8248d46247.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b06f67c-1923-41dc-9b42-1b4c79559a7e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/33e83d5c-26b0-4b18-98f3-de73fb911784.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:04.157Z.